Powered by

Senseonics Announces Equity Grants To Employees Under Inducement Plan

Oct 01, 2019 - Business Wire

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced that it has made equity grants to new employees under its 2019 Inducement Plan (the "Plan") in accordance with NYSE American Company Guide Section 711(a).

On October 1, 2019, Senseonics' Compensation Committee granted sixteen new non-executive...